Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Y Feng

Showing results (11-20 of 459) with videos related to

Pageof 46
Sort By:
Molecular and Cellular Endocrinology|November 5, 2018
Long non-coding RNAs in prostate cancer: Biological and clinical implicationsRajdeep Das, Felix Y Feng, Luke A Selth
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 13, 2009
Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based studyAron Popovtzer, Yue Cao, Felix Y Feng, et al.
European Urology|May 24, 2016
Reply to Yu-Wen Hu's Letter to the Editor re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7William C Jackson, Matthew J Schipper, Felix Y Feng
European Urology|November 8, 2017
Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65: Salvage Radiotherapy and Hormone Therapy: Change Is Coming, Just Not Quite YetDaniel E Spratt, Robert T Dess, Felix Y Feng
The Journal of Clinical Investigation|August 2, 2016
The bright side of dark matter: lncRNAs in cancerJoseph R Evans, Felix Y Feng, Arul M Chinnaiyan
Urology|February 26, 2019
AUTHOR REPLYSusan Y Wu, Felix Y Feng, Thomas A Hope
Current Drug Targets|February 16, 2013
Recurrent rearrangements in prostate cancer: causes and therapeutic potentialNicole M White, Felix Y Feng, Christopher A Maher
Urology|December 24, 2018
WITHDRAWN: PSMA-PET: a maturing toolSusan Y Wu, Felix Y Feng, Thomas A Hope
Oncology (Williston Park, N.Y.)|June 17, 2017
Emerging Categories of Disease in Advanced Prostate Cancer and Their Therapeutic ImplicationsRahul R Aggarwal, Felix Y Feng, Eric J Small
Annals of Translational Medicine|June 19, 2018
Prostate cancer in the era of "Omic" medicine: recognizing the importance of DNA damage repair pathwaysZachary Kornberg, Jonathan Chou, Felix Y Feng, et al.
Pageof 46

Showing results (11-20 of 459) with videos related to

Sort By:
Pageof 46
Molecular and Cellular Endocrinology|November 5, 2018
Long non-coding RNAs in prostate cancer: Biological and clinical implicationsRajdeep Das, Felix Y Feng, Luke A Selth
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 13, 2009
Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based studyAron Popovtzer, Yue Cao, Felix Y Feng, et al.
European Urology|May 24, 2016
Reply to Yu-Wen Hu's Letter to the Editor re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7William C Jackson, Matthew J Schipper, Felix Y Feng
European Urology|November 8, 2017
Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65: Salvage Radiotherapy and Hormone Therapy: Change Is Coming, Just Not Quite YetDaniel E Spratt, Robert T Dess, Felix Y Feng
The Journal of Clinical Investigation|August 2, 2016
The bright side of dark matter: lncRNAs in cancerJoseph R Evans, Felix Y Feng, Arul M Chinnaiyan
Urology|February 26, 2019
AUTHOR REPLYSusan Y Wu, Felix Y Feng, Thomas A Hope
Current Drug Targets|February 16, 2013
Recurrent rearrangements in prostate cancer: causes and therapeutic potentialNicole M White, Felix Y Feng, Christopher A Maher
Urology|December 24, 2018
WITHDRAWN: PSMA-PET: a maturing toolSusan Y Wu, Felix Y Feng, Thomas A Hope
Oncology (Williston Park, N.Y.)|June 17, 2017
Emerging Categories of Disease in Advanced Prostate Cancer and Their Therapeutic ImplicationsRahul R Aggarwal, Felix Y Feng, Eric J Small
Annals of Translational Medicine|June 19, 2018
Prostate cancer in the era of "Omic" medicine: recognizing the importance of DNA damage repair pathwaysZachary Kornberg, Jonathan Chou, Felix Y Feng, et al.
Pageof 46